Package 68001-525-32

{"route": ["INTRAVENOUS"], "spl_id": "4bbe6cbf-4510-e811-e063-6294a90a0e28", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["239177"], "spl_set_id": ["300304fa-4791-4455-962c-493ae467f504"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68001-525-27)  / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE", "package_ndc": "68001-525-27", "marketing_start_date": "20220218"}, {"sample": false, "description": "1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68001-525-32)  / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE", "package_ndc": "68001-525-32", "marketing_start_date": "20220218"}], "brand_name": "Fluorouracil", "product_id": "68001-525_4bbe6cbf-4510-e811-e063-6294a90a0e28", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-525", "generic_name": "Fluorouracil", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/mL"}], "application_number": "ANDA210124", "marketing_category": "ANDA", "marketing_start_date": "20220218", "listing_expiration_date": "20271231"}